CFO appointment
BeyondSpring Inc. appoints Na Li as CFO
BeyondSpring Inc. reported in a Form 8-K filed June 4, 2026 that Na Li was appointed Chief Financial Officer, effective July 1, 2026.
In the filing's words
Ms. Na Li, age 49, is appointed Chief Financial Officer of the Company, effective July 1, 2026. Ms. Li has served as Chief Financial Officer of Wanchunbulin since November 2020.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | BeyondSpring Inc. (BYSI) |
|---|---|
| Event | Appointment |
| Incoming | Na Li |
| Title in the filing | Chief Financial Officer |
| Effective | July 1, 2026 |
| 8-K filed | June 4, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Chief Financial Officer, Wanchunbulin |
| SEC CIK | 0001677940 |
BeyondSpring Inc. reported this change in a Form 8-K, Item 5.02, filed June 4, 2026. The filing's own words are quoted above.
Same industry, June 2026
8Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
4 months ago· 2026-06-30InterimIMNN
Imunon, Inc. names Josh Blacher interim CFO
4 months ago· 2026-06-30TransitionRANI
Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford
4 months ago· 2026-06-29InterimCVKD
Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO
5 months ago· 2026-06-18InterimMPLT
MapLight Therapeutics, Inc. names Jonathan Gillis interim CFO
5 months ago· 2026-06-18TransitionPTPI
Petros Pharmaceuticals, Inc. CFO transition: Robert Weinstein to succeed Mitchell Arnold
5 months ago· 2026-06-15AppointmentSNSE
Sensei Biotherapeutics, Inc. appoints Brian Stephenson as CFO
5 months ago· 2026-06-12AppointmentOCUL
Ocular Therapeutix, Inc. appoints Jason Robins as CFO
5 months ago· 2026-06-03InterimCVKD
Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Na Li? Send a correction with the primary source.